Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Immediate Communication
  • Published:

Sequence variations in CREB1 cosegregate with depressive disorders in women

Abstract

Major depressive disorder (MDD) constitutes a major public health problem worldwide and affects women twice as frequently as men. Previous linkage studies have identified a 451 kb region of 2q33–35 that exhibited significant evidence of linkage to Mood Disorders among women (but not men) from families with recurrent, early-onset MDD (RE-MDD), a severe and strongly familial subtype of MDD. This 451 kb region includes CREB1, an attractive susceptibility gene for MDD and related disorders. Sequence variations in the CREB1 promoter and intron 8 have been detected that cosegregate with Mood Disorders, or their absence, in women from these families, identifying CREB1 as a sex-limited susceptibility gene for unipolar Mood Disorders. These findings implicate the cAMP signaling pathway in the pathophysiology of Mood Disorders and related conditions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC, 1994.

  2. Robins LN, Regier DA . Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. The Free Press: New York, 1991.

    Google Scholar 

  3. US Department of Health and Human Services. Mental Health: a Report Of The Surgeon General—Executive Summary. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health: Rockville, MD, 1999.

  4. Angst J, Angst F, Stassen HH . Suicide risk in patients with major depressive disorder. J Clin Psychiatry 1999; 60(Suppl 2): 57–62.

    PubMed  Google Scholar 

  5. US Public Health Service. The Surgeon General's Call to Action to Prevent Suicide. Washington, DC, 1999. URL: http://www.surgeongeneral.gov/library/calltoaction/calltoaction.htm

  6. Zubenko GS, Zubenko WN, Spiker DG, Giles DE, Kaplan BB . Malignancy of recurrent, early-onset major depression: a family study. Am J Med Genet (Neuropsychiatr Genet) 2001; 105: 690–699.

    Article  CAS  Google Scholar 

  7. Murray CJ, Lopez AD . Evidence-based health policy: lessons from the Global Burden of Disease Study. Science 1996; 274: 740–743.

    Article  CAS  PubMed  Google Scholar 

  8. Maher BS, Marazita ML, Zubenko WN, Spiker DG, Giles DE, Kaplan BB et al. Genetic segregation analysis of recurrent, early-onset major depression: evidence for single major locus transmission. Am J Med Genet (Neuropsychiatr Genet) 2002; 114: 214–221.

    Article  Google Scholar 

  9. Zubenko GS, Hughes III HB, Stiffler JS, Zubenko WN, Kaplan BB . Genome survey for susceptibility loci for recurrent, early-onset major depression: results at 10 cM resolution. Am J Med Genet (Neuropsychiatr Genet) 2002; 114, 413–422.

    Article  Google Scholar 

  10. Zubenko GS, Hughes III HB, Maher BH, Stiffler JS, Zubenko WN, Marazita ML . Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet (Neuropsychiatr Genet) 2002; 114: 980–987.

    Article  Google Scholar 

  11. National Center for Biotechnology Information (NCBI), National Library of Medicine, National Institutes of Health. Entrez Human Map Viewer, Build 30, June 24, 2002. Chromosome 2 Map. URL: http://www.ncbi.nlm.nih.gov.

  12. Mayr B, Montminy M . Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001; 2: 599–609.

    Article  CAS  PubMed  Google Scholar 

  13. Rossby SP, Sulser F . Antidepressants: events beyond the synapse. In: Skolnick P (ed.). Antidepressants: New Pharmacological Strategies. Humana Press: Totowa NJ, 1997, pp 195–212.

    Google Scholar 

  14. Vaidya VA, Duman RS . Depression-emerging insights from neurobiology. Br Med Bull 2001; 57: 61–79.

    Article  CAS  PubMed  Google Scholar 

  15. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM . Neurobiology of depression. Neuron 2002; 34: 13–25.

    Article  CAS  PubMed  Google Scholar 

  16. Weeber EJ, Sweatt JD . Molecular biology of human cognition. Neuron 2002; 33: 845–848.

    Article  CAS  PubMed  Google Scholar 

  17. Zubenko GS . Do susceptibility loci contribute to the expression of more than one mental disorder? A view from the genetics of Alzheimer's disease. Mol Psychiatry 2000; 5: 131–136.

    Article  CAS  PubMed  Google Scholar 

  18. Lazennec G, Thomas JA, Katznellenbogen BS . Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators. J Steroid Biochem Mol Biol 2001; 77: 193–203.

    Article  CAS  PubMed  Google Scholar 

  19. McEwen BS . Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001; 91: 2785–2801.

    Article  CAS  PubMed  Google Scholar 

  20. Tremblay A, Giguere V . Contribution of steroid receptor co-activator-1 and CREB binding protein in ligand-independent activity of estrogen receptor β. J Steroid Biochem Mol Biol 2001; 77: 19–27.

    Article  CAS  PubMed  Google Scholar 

  21. Spitzer RL, Endicott J . Schedule for Affective Disorders and Schizophrenia—Lifetime Version. New York State Psychiatric Institute, Biometrics Research: New York, 1975.

    Google Scholar 

  22. Puig-Antich J, Orvaschel H, Tabrizi MA, Chambers W . The Schedule for Affective Disorders and Schizophrenia for School Children—Epidemiologic Version (Kiddie-SADS-E) 3rd edn. New York State Psychiatric Institute and Yale University School of Medicine, New York, 1980.

  23. Andreasen NC, Rice J, Endicott J, Reich T, Coryell W . The family history approach to diagnosis. How useful is it? Arch Gen Psychiatry 1986; 43: 421–429.

    Article  CAS  PubMed  Google Scholar 

  24. Weissman MM, Merikangas KR, John K, Wickramaratne P, Prusoff BA, Kidd KK . Family genetic studies of psychiatric disorders. Arch Gen Psychiatry 1986; 43: 1104–1116.

    Article  CAS  PubMed  Google Scholar 

  25. Endicott J, Andreasen N, Spitzer RL . Family History—Research Diagnostic Criteria. New York State Psychiatric Institute, Biometrics Research: New York, 1975.

    Google Scholar 

  26. Spitzer RL, Endicott J, Robins E . Research diagnostic criteria. Rationale and reliability. Arch Gen Psychiatry 1978; 35: 773–782.

    Article  CAS  PubMed  Google Scholar 

  27. Zubenko GS, Stiffler JS, Hughes III HB, Fatigati MJ, Zubenko WN . Genome survey for loci that influence successful aging: sample characterization, method validation, and initial results for the Y chromosome. Am J Geriatr Psychiatry 2002; 10: 619–630.

    Article  PubMed  Google Scholar 

  28. Zubenko GS, Hughes HB III, Stiffler JS, Zubenko WN, Kaplan BB . D2S2944 identifies a likely susceptibility locus for recurrent, early-onset, major depression in women. Mol Psychiatry 2002; 7: 460–467.

    Article  CAS  PubMed  Google Scholar 

  29. Rozen S, Skaletsky HJ . Primer 3 on the www for general users and for biologist programmers. In: Krawetz S, Misener S (eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology. Humana Press: Totowa, NJ, 2000, pp 365–386.

    Google Scholar 

  30. S.A.G.E. Statistical analysis for genetic epidemiology, Release 4.2. Computer program package available from the Department of Epidemiology and Biostatistics, Case Western Reserve University, 2002.

  31. Lander ES, Green P . Construction of multilocus genetic maps in humans. Proc Natl Acad Sci USA 1987; 84: 2363–2367.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Sobel E, Lange K . Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 1996; 58: 1323–1337.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Olson JM . A general conditional-logistic model for affected-relative-pair linkage studies. Am J Hum Genet 1999; 65: 1760–1769.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Risch N . Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analyses of affected relative pairs. Am J Hum Genet 1990; 46: 242–253.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Goddard KAB, Witte JS, Suarez BK, Catalona WJ, Olson JM . Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001; 68: 1197–1206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL . Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 1998; 63: 861–869.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Meyer TE, Waeber G, Lin J, Beckmann W, Habener JF . The promoter of the gene encoding 3′,5′-cyclic adenosine monophosphate (cAMP) response element binding protein contains cAMP response elements: evidence for positive autoregulation of gene transcription. Endocrinology 1993; 132: 770–780.

    Article  CAS  PubMed  Google Scholar 

  38. Petrij F, Giles R, Breuning M and Hennekam RCM . Rubinstein-Taybi syndrome. In: Shriver CR, Baudet A, Sly W, Valle D (eds). The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill: New York, 2002, pp 6167–6182.

    Google Scholar 

  39. Levitas AS, Reid CS . Rubenstein–Taybi syndrome, and psychiatric disorders. J Intellect Disabil Res 1998; 42: 284–292.

    Article  PubMed  Google Scholar 

  40. Murata T, Kurokawa R, Krones A, Tatsumi K, Ishii M, Taki T . Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein–Taybi syndrome. Hum Mol Genet 2001; 10: 1071–1076.

    Article  CAS  PubMed  Google Scholar 

  41. Kalkoven E, Roelfsema JH, Teunissen H, den Boer A, Ariyurek Y, Zantema A et al. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein–Taybi syndrome. Hum Mol Genet 2003; 12: 441–450.

    Article  Google Scholar 

  42. Selkoe DJ, Podlisny MB . Deciphering the genetic basis of Alzheimer's disease. Annu Rev Genomics Hum Genet 2002; 3: 67–99.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The previous contributions of the research staff of this project, and the families who participated, are gratefully acknowledged. This work was supported by research project Grants MH48969 and MH60866 (GSZ). Automated DNA sequencing was performed by the Genomics and Proteomics Core Laboratories of the University of Pittsburgh. Some of the results of this study were obtained using S.A.G.E., supported by US Public Health Service Resource Grant 1-P41-RR03655. GSZ was the recipient of Independent Scientist Award MH00540 from the National Institute of Mental Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G S Zubenko.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zubenko, G., Hughes, H., Stiffler, J. et al. Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatry 8, 611–618 (2003). https://doi.org/10.1038/sj.mp.4001354

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001354

Keywords

This article is cited by

Search

Quick links